Similar articles

• Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.

  Vakil N, Fennerty MB. Vakil N, et al. Am J Gastroenterol. 1996 Feb;91(2):239-45. Am J Gastroenterol. 1996. PMID: 8607487
• [Treatment of Helicobacter pylori infections].

  Calvet Calvo X. Calvet Calvo X. Gastroenterol Hepatol. 1998 Apr;21(4):203-6. Gastroenterol Hepatol. 1998. PMID: 9633184 Review. Spanish. No abstract available.
• Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.

  de Boer WA, Haeck PW, Otten MH, Mulder CJ. de Boer WA, et al. Am J Gastroenterol. 1998 Jul;93(7):1101-7. doi: 10.1111/j.1572-0241.1998.00337.x. Am J Gastroenterol. 1998. PMID: 9672338 Clinical Trial.
• Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?

  de Boer WA, Kuipers EJ, Kusters JG. de Boer WA, et al. Dig Liver Dis. 2004 May;36(5):311-4. doi: 10.1016/j.dld.2004.01.016. Dig Liver Dis. 2004. PMID: 15191198 Review. No abstract available.
• The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.

  Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A. Bago J, et al. Wien Klin Wochenschr. 2002 Jun 28;114(12):448-53. Wien Klin Wochenschr. 2002. PMID: 12422579 Clinical Trial.